Search

Your search keyword '"López‐Reyes, R"' showing total 116 results

Search Constraints

Start Over You searched for: Author "López‐Reyes, R" Remove constraint Author: "López‐Reyes, R"
116 results on '"López‐Reyes, R"'

Search Results

1. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

2. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

3. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

4. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

5. Timing and characteristics of venous thromboembolism after noncancer surgery

6. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

7. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

8. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

9. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

10. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

11. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

12. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

13. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

15. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

16. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

17. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

18. DVT Management and Outcome Trends, 2001 to 2014

19. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

20. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

23. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

24. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

25. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

26. Thrombotic Risk and Covid-19: Review of Current Evidence for a Better Diagnostic and Therapeutic Approach

27. From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?

28. Timing and characteristics of venous thromboembolism after noncancer surgery

29. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

30. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

31. FRI0242 IMPACT OF PULMONARY ARTERIAL HYPERTENSION WITH OR WITHOUT INTERSTITIAL LUNG DISEASE ON SCLERODERMA: A RETROSPECTIVE COHORT STUDY FROM THE NATIONWIDE SPANISH SCLERODERMA (RESCLE) AND PULMONARY ARTERIAL HYPERTENSION (REHAP) REGISTRIES

32. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

33. Portopulmonary hypertension: prognosis and management in the current treatment era. Results from the REHAP Registry

34. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

35. Obstructive sleep apnoea and venous thromboembolism: pathophysiological links and clinical implications

36. Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry

37. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

38. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

39. Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.

41. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

42. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

43. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

44. Clinical Characteristics and Survival of Patients with Pulmonary Hypertension: A 40-Month Mean Follow-Up

46. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

47. DVT Management and Outcome Trends, 2001 to 2014

48. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

49. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

50. Espondilodiscitis infecciosa. Un reto diagnóstico. Informe de un caso.

Catalog

Books, media, physical & digital resources